Sales Growth YoY (Last Twelve Months): Agape ATP Corporation (ATPC)

Graphic logo of agapeatpgroup.com (ATPC)

Agape ATP Corporation (ATPC) is facing regulatory challenges and insufficient reporting transparency within its Asian structure. Intense competition from the wellness sector and low barriers to entry create additional risks. The year-over-year sales trajectory over the trailing four quarters demonstrates revenue dynamics, where -26.50 characterizes this valuation parameter. Meanwhile, the brand maintains strong loyalty among wellness program consumers in the Eastern region.

Sales Growth YoY (Last Twelve Months): agapeatpgroup.com (ATPC) for 11/23/2025 - 11/18/2026

Agape ATP Corp (ATPC) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:ATPC, agapeatpgroup.com
Mass-produced product of Agape ATP

Investors are seeking confirmation of business model scalability within the Agape ATP Corporation (ATPC) financial reports. This metric measures the percentage shift in revenue over a rolling year, neutralizing seasonal distortions. By analyzing the Last Twelve Months (LTM) growth rate of commercial revenue, one can assess the effectiveness of acquiring new users via digital services. This price action reflects the viability of the wellness ecosystem and the loyalty of the elderly demographic. Steady growth here confirms the resilience of the company's fundamental base.

Who Agape ATP Corporation competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)